Ferroptosis as a target for protection against cardiomyopathy.
Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X, Cheng Q, Zhang P, Dai W, Chen J, Yang F, Yang HT, Linkermann A, Gu W, Min J, Wang F.
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2672-2680. doi: 10.1073/pnas.1821022116. Epub 2019 Jan 28.
Mourning and Takotsubo cardiomyopathy: neuroendocrine implications and nutritional management.
Campos MTFS, Valente FMQ, Araújo RMA, Bressan J.
Rev Assoc Med Bras (1992). 2018 Oct;64(10):952-959. doi: 10.1590/1806-9282.64.10.952.
Redefining Cirrhotic Cardiomyopathy for the Modern Era.
Izzy M, VanWagner LB, Lin G, Altieri M, Findlay JY, Oh JK, Watt KD, Lee SS; Cirrhotic Cardiomyopathy Consortium.
Hepatology. 2020 Jan;71(1):334-345. doi: 10.1002/hep.30875. Epub 2019 Oct 11.
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).
Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera JA, Chugh SS, de Groot JR, Soulat-Dufour L, Fenelon G, Hatem SN, Jalife J, Lin YJ, Lip GYH, Marcus GM, Murray KT, Pak HN, Schotten U, Takahashi N, Yamaguchi T, Zoghbi WA, Nattel S, Mont L, Akar JG, Akoum N, Althoff T, Diaz JC, Guichard JB, Jadidi A, Kalman J, Lim H, Teixeira RA.
Europace. 2024 Aug 30;26(9):euae204. doi: 10.1093/europace/euae204.
Retrospective study of dilated cardiomyopathy in dogs.
Freid KJ, Freeman LM, Rush JE, Cunningham SM, Davis MS, Karlin ET, Yang VK.
J Vet Intern Med. 2021 Jan;35(1):58-67. doi: 10.1111/jvim.15972. Epub 2020 Dec 21.
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis.
Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F, Yu Y, Song Z, Wu Q, An P, Huang S, Pan J, Chen HZ, Chen J, Linkermann A, Min J, Wang F.
Circ Res. 2020 Jul 31;127(4):486-501. doi: 10.1161/CIRCRESAHA.120.316509. Epub 2020 Apr 30.
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.
Tadros R, Francis C, Xu X, Vermeer AMC, Harper AR, Huurman R, Kelu Bisabu K, Walsh R, Hoorntje ET, Te Rijdt WP, Buchan RJ, van Velzen HG, van Slegtenhorst MA, Vermeulen JM, Offerhaus JA, Bai W, de Marvao A, Lahrouchi N, Beekman L, Karper JC, Veldink JH, Kayvanpour E, Pantazis A, Baksi AJ, Whiffin N, Mazzarotto F, Sloane G, Suzuki H, Schneider-Luftman D, Elliott P, Richard P, Ader F, Villard E, Lichtner P, Meitinger T, Tanck MWT, van Tintelen JP, Thain A, McCarty D, Hegele RA, Roberts JD, Amyot J, Dubé MP, Cadrin-Tourigny J, Giraldeau G, L'Allier PL, Garceau P, Tardif JC, Boekholdt SM, Lumbers RT, Asselbergs FW, Barton PJR, Cook SA, Prasad SK, O'Regan DP, van der Velden J, Verweij KJH, Talajic M, Lettre G, Pinto YM, Meder B, Charron P, de Boer RA, Christiaans I, Michels M, Wilde AAM, Watkins H, Matthews PM, Ware JS, Bezzina CR.
Nat Genet. 2021 Feb;53(2):128-134. doi: 10.1038/s41588-020-00762-2. Epub 2021 Jan 25.
Cardiac Slc25a49-Mediated Energy Reprogramming Governs Doxorubicin-Induced Cardiomyopathy through the G6P-AP-1-Sln Axis.
Wan S, Qi J, Xia Y, Fan C, Xu T, Zhang X, Shi J, Wang C, Cheng Y, Zhang D, Liu R, Zhu Y, Cao C, Jin D, An P, Luo Y, Luo J.
Adv Sci (Weinh). 2025 Jul;12(26):e2502163. doi: 10.1002/advs.202502163. Epub 2025 Apr 4.
[Alcoholic cardiomyopathy].
Rossi MA, Zucoloto S.
Acta Med Port. 1984 Jul-Aug;5(7-8):223-34.
Peripartum cardiomyopathy.
Moioli M, Valenzano Menada M, Bentivoglio G, Ferrero S.
Arch Gynecol Obstet. 2010 Feb;281(2):183-8. doi: 10.1007/s00404-009-1170-5. Epub 2009 Aug 5.
